About RCT
RCT is a venture capital firm founded in 1987. It is primarily based out of Tucson, United States. As of Oct 2025, RCT is an active investor, having invested in 56 companies, with 1 new investment in the last 12 months. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Codis Overall, RCT portfolio has seen 2 IPOs and 18 acquisitions including key companies like S2 Genomics, Orflo and Catalyst Biosciences. A lot of funds co-invest with RCT, with names like Broadoak Capital Partners sharing a substantial percentage of its portfolio. RCT has team of 13 people including 7 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 4 more
Portfolio IPOs
Portfolio Acquisitions
Deals in last 12 months
RCT's List of Top Investments
RCT has a portfolio of 56 companies. Their most notable investments are in AustinPx and AustinPx.Their portfolio spans across United States, United Kingdom, India and 1 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 6 other sectors, across stages such as Series A, Series B and 4 more. Here is the list of top investments by RCT:1. OrthAlign
Developer of computer-assisted surgery technology for hip and knee joint replacement. The company provides technology for total hip arthroplasty, total knee arthroplasty, revision knee arthroplasty, and partial knee arthroplasty. Their products are designed for use in ambulatory surgery centers.
Key facts about OrthAlign
- Founded Year: 2008
- Location: Aliso Viejo (United States)
- Stage: Series D
- Total Funding till date: $56M
- Employee Count: 131 as on May 31, 2026
- Investors: Allumia Ventures, Okapi Venture Capital and 4 Others
- Latest Funding Round: Series D, Sep 02, 2020, $*****
- Highlight: Editors' Pick
2. GoDesi
Internet first brand of desi snacks and sweets. The company offers a variety of sweets, snacks, and lollipops. It focuses on bringing authentic desi snacks to consumers. The company employs rural women and ensures that a percentage of consumer payments goes back to the rural economy. Its products are free from preservatives, artificial colors, flavors, vegan and gluten-free.
Key facts about GoDesi
3. seqWell
Provider of NGS-based reagents and kits for life sciences research. The company has developed a plexWell platform, transformative technology for parallelized library prep that allows for simple, easy multiplexing of 100s to 1000s of distinct samples. The company's Illumina-compatible plexWell Library Preparation technology permits an order-of-magnitude improvement in the number of samples that can be prepared and readily sequenced on benchtop NGS instruments.
Key facts about seqWell
- Founded Year: 2014
- Location: Beverly (United States)
- Stage: Series C
- Total Funding till date: $24.5M
- Employee Count: 39 as on May 31, 2026
- Investors: CYwP Funds, RCT and 3 Others
- Latest Funding Round: Series C, Sep 16, 2024, $*****
- Highlight: Editors' Pick
4. S2 Genomics
Developer of automated sample preparation systems for genomics. The company is developing single-cell sample preparations solutions for NGS. Their systems are used for processing tissues and liquid samples into genomic samples. The company is also developing a spatial sequencing technology that will capture the spatial location like 3-dimensional coordinates, of single cells in tissue for NGS readout.
Key facts about S2 Genomics
- Founded Year: 2016
- Location: Livermore (United States)
- Stage: Acquired
- Total Funding till date: $16M
- Employee Count: 6 as on May 31, 2026
- Investors: Tri-Valley Ventures, R42 Group and 6 Others
- Latest Funding Round: Series A, Jan 23, 2024, $*****
- Highlight: Acquired
5. Biolog
Provider of cell-based phenotyping technologies and assays. The company's technologies include the Biolog Microbial ID System which can rapidly identify over 2,900 species of aerobic and anaerobic bacteria, yeasts, and fungi, Rainbow Agar Chromogenic Media for microbial detection, EcoPlates for simplified microbial community analysis and Phenotype MicroArrays to quantitatively measure thousands of cellular phenotypes in parallel. The company also provides research services on Phenotype MicroArrays.
Key facts about Biolog
- Founded Year: 1984
- Location: Hayward (United States)
- Stage: Series A
- Total Funding till date: $33.6M
- Employee Count: 135 as on May 31, 2026
- Investors: RCT, Broadoak Capital Partners and 2 Others
- Latest Funding Round: Series A, Feb 10, 2025, $*****
- Highlight: Editors' Pick
RCT's Year-on-Year Investment Trends
RCT has invested in 58 companies over the last 25 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 1 investment. Its most recent first time investment was in Codis and most recent follow-on round was in Pheon Therapeutics.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 1 | 0 | 1 |
2024 | 1 | 1 | 2 |
2023 | 2 | 0 | 2 |
2022 | 3 | 2 | 5 |
2021 | 1 | 0 | 1 |
2020 | 1 | 1 | 2 |
2019 | 0 | 0 | 0 |
2018 | 2 | 1 | 3 |
2017 | 0 | 1 | 1 |
RCT's Investments by Stage
RCT is primarily an Early Stage Investor investor majorly investing in Series A (15) rounds where average round size is $239M, Series B (7) rounds where average round size is $81.6M and Seed (2) rounds where average round size is $0.Stage of entry | No. of Investments |
|---|---|
Series A | 15 |
Series B | 7 |
Seed | 2 |
Series C | 2 |
Grant (prize money) | 1 |
Others | 1 |
Note: We have considered here, only first round of investments
RCT's Investments by Sector
RCT has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Healthcare, Enterprise Applications and Consumer Goods. Notably, it has invested in 38 Tech companies, 37 Enterprise (B2B) companies, 14 Software companies and at least 7 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 24 |
High Tech | 7 |
Healthcare | 3 |
Enterprise Applications | 2 |
Consumer Goods | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
RCT's Investments by Geography
RCT has made most investments in United States (23), followed by United Kingdom where it has made 3 investments.Country | No. of Investments |
|---|---|
United States | 23 |
United Kingdom | 3 |
India | 1 |
Note: We have considered here, only first round of investments
RCT's recent investments
RCT has not made any investment in 2026 so far.Here are the most recent investments by RCT:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 16, 2025 | - | Seed | 4394 | [+1] | |
May 21, 2024 | United Kingdom | Series B | 7482 | [+6] | |
Jan 23, 2024 | United States | Series A | 5694 | ||
Jul 26, 2023 | United States | Series A | 5523 | ||
Jan 04, 2023 | United States | Series A | 8485 |
IPOs and Publicly Listed companies in RCT's Portfolio
2 of RCT's portfolio companies have become public. Catalyst Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2006 at marketcap of $172M and Bionomics got listed on the Australian Securities Exchange (ASX) at marketcap of $6.52M.Here are RCT's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 13, 2006 | Feb 09, 2006 | Series B | 3970 | |
Dec 21, 1999 | - | - | 3416 |
Acquired companies in RCT's Portfolio
18 companies from RCT's portfolio have been acquired. The most recent acquisition was Orflo.Here are RCT's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 17, 2025 | Apr 16, 2014 | Series A | 8518 | |
Sep 17, 2025 | Jan 23, 2024 | Series A | 5132 | |
May 21, 2025 | Dec 20, 2018 | Series B | 4491 | |
Dec 31, 2020 | - | - | 4386 | |
Mar 12, 2019 | - | - | 8423 |
Team profile of RCT
RCT has a team of 13 members including 7 Partners and 2 Principals located in United States. RCT's team sits on the board of 2 companies.Here is a list of top team members in RCT:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Tucson | - | ||
Partner | Tucson | - | ||
Partner | San Francisco | - | ||
Partner | Tucson | |||
Partner | Atlanta | - | - | |
Partner | East Rutherford | - | - | |
Partner | Tucson | - | ||
Principal | Tucson | |||
Principal | Los Angeles | - | - |
Co-investors of RCT
Over the past 25 years, 128 investors have co-invested in RCT's portfolio companies. This includes funds and angels.
- Invested before RCT: HHS, National Science Foundation and 49 others have invested in rounds before RCT. There are 5 companies where HHS has invested before RCT and 3 companies where National Science Foundation has invested before RCT.
- Top Co-investors of RCT: 33 investors entered a company along with RCT. These include investors like Broadoak Capital Partners (8 companies).
- Invested after RCT: A total of 44 investors have invested in RCT's portfolio after their investments. Top Investors include Novartis (2 companies), RC Capital (1 company) and California Technology Ventures (1 company).
Recent News related to RCT
•
•
Pheon Therapeutics Raises $120M in Series B FinancingFinSMEs•May 21, 2024•Pheon Therapeutics, TCG Crossover, BVF Partners, Lightspeed Venture Partners and 8 others
•
S2 Genomics Raises Series A Round Led by BroadOak Capital Partners and RCTintelligence360•Jan 24, 2024•S2 Genomics, Broadoak Capital Partners, RCT, RCT Ventures
•
iotaMotion Raises $12M Series ASilicon Valley Journals•Jul 27, 2023•IotaMotion, RCT, Mutual Capital Partners, ISA Ventures and 1 other
•
•
Halo Labs Completes $6M Growth FinancingContract Pharma•Jul 11, 2022•Halo Labs, Agilent, RCT, Broadoak Capital Partners and 1 other
•
•
SeqWell Partners With Codexis; Raises $7M in Series C FundingGenomeWeb•Apr 21, 2022•Codexis, seqWell, Broadoak Capital Partners, RCT
•
•
